Clinical Research Directory
Browse clinical research sites, groups, and studies.
Systematic Ambulatory ECG Monitoring Following TAVI
Sponsor: Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
Summary
This multicenter, prospective, randomized superiority trial will evaluate whether systematic 14-day ambulatory ECG monitoring following hospital discharge after transcatheter aortic valve implantation (TAVI) reduces the risk of sudden death, symptomatic arrhythmic events, or stroke within 1 year compared with standard post-discharge care. Patients undergoing successful TAVI without permanent pacemaker implantation and presenting with at least one ECG conduction abnormality at hospital discharge will be randomized to receive either ambulatory ECG monitoring or standard follow-up. All participants will undergo routine clinical follow-up at 30 days and 1 year after TAVI.
Official title: Systematic Ambulatory ECG Monitoring Following TAVI: A Prospective Randomized Trial.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
754
Start Date
2026-08
Completion Date
2028-12
Last Updated
2026-07-31
Healthy Volunteers
No
Conditions
Interventions
Ambulatory ECG monitoring
Participants randomized to the intervention arm will undergo systematic ambulatory ECG monitoring at hospital discharge following the TAVI procedure. A wearable ambulatory ECG monitoring device will be applied for continuous rhythm monitoring during a 14-day period. The device will allow detection of clinically significant bradyarrhythmias and tachyarrhythmias. Detected arrhythmic events will be reviewed by the study team, and appropriate clinical management, including further evaluation or therapeutic intervention, will be performed according to the nature of the detected abnormality and standard clinical practice.
Locations (1)
Institut universitaire de cardiologie et de pneumologie de Québec - UL
Québec, Quebec, Canada